Mirum Pharmaceuticals Inc...

45.06
-0.93 (-2.02%)
At close: Mar 31, 2025, 3:59 PM
44.55
-1.14%
After-hours: Mar 31, 2025, 07:56 PM EDT

Mirum Pharmaceuticals Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -22.34 -7.39 -4.86 -5.76 -4.27 -10.73 -17.51
PEG Ratio 0.42 29.62 -0.11 0.18 -0.05 -0.05 n/a
PS Ratio 5.83 6.48 8.56 25.27 n/a n/a n/a
PB Ratio 8.71 4.85 -1.68 4.02 -2.55 -8.06 -29.42
P/FCF Ratio 210.57 -13.26 -5.48 -3.19 -4.94 -14.22 -38.57
P/OCF Ratio 190.32 -17.01 -5.49 -3.64 -4.95 -14.32 -814.2
OCF/S Ratio 0.03 -0.38 -1.56 -6.94 n/a n/a n/a
Debt / Equity Ratio 1.41 1.24 -0.01 0.02 -0.02 -0.05 n/a
Quick Ratio 2.93 4.19 2.85 3.88 12.80 9.13 21.22
Current Ratio 3.10 4.45 2.94 3.91 12.80 9.13 21.22
Asset Turnover 0.50 0.29 0.22 0.06 n/a n/a n/a
Interest Coverage -6.12 -7.23 -8.21 -9.86 -311.33 n/a n/a
Return on Equity (ROE) -0.39 -0.66 0.35 -0.7 0.60 0.75 1.68
Return on Assets (ROA) -0.13 -0.25 -0.38 -0.29 -0.43 -0.36 -0.33
Return on Capital (ROIC) -0.16 -0.2 -0.46 -0.69 -0.47 -0.41 -0.06
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 75.77% 74.76% 83.94% 90.06% n/a n/a n/a
Net Profit Margin -26.1% -87.68% -176.05% -438.85% n/a n/a n/a
Pretax Profit Margin -25.8% -87.15% -184.36% -438.66% n/a n/a n/a
Operating Profit Margin -26% -58.57% -170.28% -906.12% n/a n/a n/a
FCF Margin 2.77% -48.85% -156.26% -793.09% n/a n/a n/a
EBITDA Margin -14.54% -73.23% -158.85% -341.66% n/a n/a n/a